Mo Atta
Distinguished in Chronic Kidney Disease

Dr. Mo Atta

Nephrology
Johns Hopkins Medicine
Johns Hopkins Outpatient Center
601 North Caroline Street, Floor 7, Floor 7, 
Baltimore, MD 
34 Years of Experience

Distinguished in Chronic Kidney Disease
Johns Hopkins Medicine
Johns Hopkins Outpatient Center
601 North Caroline Street, Floor 7, Floor 7, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others.

Dr. Atta is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 20 articles in the study of Chronic Kidney Disease.

Graduate Institution
Johns Hopkins Bloomberg School Of Public Health, MPH, 2005
Residency
Cabrini Medical Center of New York City, Medicine, 1994
Specialties
Nephrology
Licenses
Internal Medicine in MD
Fellowships
Johns Hopkins University School of Medicine, Nephrology, 1997
Hospital Affiliations
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Arabic
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Johns Hopkins Outpatient Center
601 North Caroline Street, Floor 7, Floor 7, Baltimore, MD 21287
Call: 410-955-0670
Other Locations
The Johns Hopkins Hospital
1717 East Monument Street, Park Building, Ground Level, Baltimore, MD 21287
Call: 410-955-0670
Johns Hopkins Bayview Medical Center
301 Mason Lord Drive, Suite 3400, Baltimore, MD 21224
Call: 410-550-1800

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
View 2 Less Clinical Trials

94 Total Publications

Aggressive Recurrent Tumoral Calcinosis in a Patient With Kidney Failure.
Aggressive Recurrent Tumoral Calcinosis in a Patient With Kidney Failure.
Journal: Kidney medicine
Published: November 10, 2025
View All 94 Publications
Similar Doctors
Deidra Crews
Elite in Chronic Kidney Disease
Dr. Deidra Crews
Nephrology
Elite in Chronic Kidney Disease
Dr. Deidra Crews
Nephrology

The Johns Hopkins Hospital

1800 Orleans Street, 
Baltimore, MD 
 (0.1 miles away)
410-955-5000
Experience:
18+ years
Languages Spoken:
English
See accepted insurances

Dr. Crews is a Professor of Medicine in the Division of Nephrology at the Johns Hopkins University School of Medicine. She holds faculty appointments with the School of Nursing, the Welch Center for Prevention, Epidemiology and Clinical Research, the Center on Aging and Health, and the Center for Health Equity, where she is Deputy Director. Her research program aims to advance equity in kidney disease and hypertension outcomes by focusing on social drivers of health inequities. An elected member of the American Society for Clinical Investigation, Dr. Crews has received numerous awards for her research contributions, including the 2018 Johns Hopkins University President’s Frontier Award--a $250,000 award granted to a single faculty scholar on the cusp of transforming their field. She is a former National Academy of Medicine (NAM) Emerging Leader Scholar and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. In 2019, Dr. Crews received the W. Lester Henry Award for Diversity and Access to Care from the American College of Physicians and the Distinguished Leader Award from the American Society of Nephrology. Dr. Crews is the founding director of the Doctoral Diversity Program, a 2-year, research-intensive post-baccalaureate program of the Johns Hopkins Initiative for Careers in Science and Medicine. Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master’s in clinical epidemiology degree at Johns Hopkins. Dr. Crews is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Arteriovenous Malformation, Kidney Transplant, and Nephrectomy.

Bernard G. Jaar
Elite in Chronic Kidney Disease
Dr. Bernard G. Jaar
Nephrology
Elite in Chronic Kidney Disease
Dr. Bernard G. Jaar
Nephrology

Johns Hopkins Bayview Medical Center

301 Mason Lord Drive, Suite 3400, Suite 3400, 
Baltimore, MD 
 (3.1 miles away)
410-550-1800
Languages Spoken:
English, French
See accepted insurances
Offers Telehealth

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Low Potassium Level, and Kidney Transplant.

Elite in Chronic Kidney Disease
Dr. Michelle M. Estrella
Nephrology
Elite in Chronic Kidney Disease
Dr. Michelle M. Estrella
Nephrology
600 N Wolfe St, 
Baltimore, MD 
 (0.1 miles away)
410-955-5268
Languages Spoken:
English

Michelle Estrella is a Nephrologist in Baltimore, Maryland. Dr. Estrella is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Focal Segmental Glomerulosclerosis, Prerenal Azotemia, and Kidney Transplant.

VIEW MORE CHRONIC KIDNEY DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Atta's expertise for a condition
ConditionClose
    • Distinguished
    • Chronic Kidney Disease
      Dr. Atta is
      Distinguished
      . Learn about Chronic Kidney Disease.
      See more Chronic Kidney Disease experts
    • End-Stage Renal Disease (ESRD)
      Dr. Atta is
      Distinguished
      . Learn about End-Stage Renal Disease (ESRD).
      See more End-Stage Renal Disease (ESRD) experts
    • Glomerulonephritis
      Dr. Atta is
      Distinguished
      . Learn about Glomerulonephritis.
      See more Glomerulonephritis experts
    • Lupus Nephritis
      Dr. Atta is
      Distinguished
      . Learn about Lupus Nephritis.
      See more Lupus Nephritis experts
    • Advanced
    • Acute Kidney Failure
      Dr. Atta is
      Advanced
      . Learn about Acute Kidney Failure.
      See more Acute Kidney Failure experts
    • Fabry Disease
      Dr. Atta is
      Advanced
      . Learn about Fabry Disease.
      See more Fabry Disease experts
    • Focal Segmental Glomerulosclerosis
      Dr. Atta is
      Advanced
      . Learn about Focal Segmental Glomerulosclerosis.
      See more Focal Segmental Glomerulosclerosis experts
    • Interstitial Nephritis
      Dr. Atta is
      Advanced
      . Learn about Interstitial Nephritis.
      See more Interstitial Nephritis experts
    • Kidney Transplant
      Dr. Atta is
      Advanced
      . Learn about Kidney Transplant.
      See more Kidney Transplant experts
    • Nephrosclerosis
      Dr. Atta is
      Advanced
      . Learn about Nephrosclerosis.
      See more Nephrosclerosis experts
    View All 8 Advanced Conditions
    • Experienced
    • Autosomal Dominant Polycystic Kidney Disease
      Dr. Atta is
      Experienced
      . Learn about Autosomal Dominant Polycystic Kidney Disease.
      See more Autosomal Dominant Polycystic Kidney Disease experts
    • Calcinosis
      Dr. Atta is
      Experienced
      . Learn about Calcinosis.
      See more Calcinosis experts
    • Childhood Hypophosphatasia (HPP)
      Dr. Atta is
      Experienced
      . Learn about Childhood Hypophosphatasia (HPP).
      See more Childhood Hypophosphatasia (HPP) experts
    • Congenital Nephrotic Syndrome
      Dr. Atta is
      Experienced
      . Learn about Congenital Nephrotic Syndrome.
      See more Congenital Nephrotic Syndrome experts
    • Diabetic Nephropathy
      Dr. Atta is
      Experienced
      . Learn about Diabetic Nephropathy.
      See more Diabetic Nephropathy experts
    • Feingold Syndrome
      Dr. Atta is
      Experienced
      . Learn about Feingold Syndrome.
      See more Feingold Syndrome experts
    View All 24 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.